Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company developing next-generation cardiovascular therapeutics, and its clinical development division Sardocor, today announced that the U.S.
ESCMID is the premier annual congress of the European Society of Clinical Microbiology and Infectious Diseases. It takes place from April 17 - 21, 2026 in Munich, Germany.
Morning Overview on MSN
Study of immune memory points to new paths against deadly disease
A macrophage that has already fought off one infection does not return to a blank slate. It carries chemical scars, etched ...
Avalyn Pharma's IPO aims to fund inhaled IPF therapies as AP01 shows positive Phase II results. Read the full analysis here.
There seems to be a strong exposure-response relationship between nerandomilast and the preservation of FVC in patients with PPF and IPF.
Nerandomilast may represent a meaningful addition to the treatment arsenal, offering patients and clinicians a new option for pulmonary fibrosis. A new systematic review and meta-analysis suggests ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In children aged 3 to 12 years, myopia progressed 0.77 D ...
After a few months away from the spotlight, the royal who suffers from lung disease pulmonary fibrosis made a public ...
A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...
This editorial by Lucas Grundmeier represents the views of the Register's editorial board. The new report “Miracle of Breath” from the Register’s Iowa columnist, Courtney Crowder, spans decades to ...
The influential AI researcher François Chollet has long argued that the field measures intelligence incorrectly, that popular benchmarks reward a model’s ability to memorize vast amounts of data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results